Full Press Release Details
INDIANAPOLIS , Aug. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will participate in the Morgan Stanley 23 rd Annual Global Healthcare Conference on Sept. 8, 2025. Jacob Van Naarden, executive vice president and president of Lilly Oncology, and David Hyman , M.D., Lilly chief medical officer will take part in a fireside chat at 9:15 a.m., Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.
Trademarks and Trade Names All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
| Refer to: | Ashley Hennessey; [email protected] ; 317-416-4363 (Media) |
| Michael Czapar; [email protected] ; 317-617-0983 (Investors) |
SOURCE Eli Lilly and Company